
    
      This study is to evaluate whether PED-1 is effective than Placebo in the treatment of
      premature ejaculation. The patients will be randomized and allocated to two treatment groups
      into placebo, PED-1. The criteria for Intravaginal Ejaculation Latency Time(IELT) for
      enrollment will be > or =2 min in the at least 75% of the sexual intercourse. To diagnosis
      premature ejaculation, the PEDT(Premature Ejaculation Diagnosis Tool) will be used. The
      patients undergone drug free baseline period will take test drugs for 12 weeks.
    
  